Percheron Therapeutics Limited (ASX:PER)

Australia · Delayed Price · Currency is AUD

0.0050

-0.0005 (-9.09%)

Aug 21, 2026, 2:58 PM AEST

Percheron Therapeutics Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	0.84	0.84	1.8	2.97	1.96	1.78
Revenue Growth	-51.45%	-53.16%	-39.32%	51.07%	10.51%	207.72%
Gross Profit	0.66	0.66	1.63	2.91	1.93	1.71
Operating Income	-4.78	-4.78	-14.91	-11.92	-11.38	-5.83
Net Income	-4.79	-4.79	-14.92	-11.92	-11.38	-5.81
Earnings Per Share	-0.00	-0.00	-0.01	-0.01	-0.02	-0.01
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Unallocated	0.37	0.62	0.38	-
ATL1102	1.43	2.35	1.58	1.78
Total	1.8	2.97	1.96	1.78

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Investments	4.05	4.05	10.17	11.87	10.97	19.23
Total Debt	0.03	0.03	0.03	0.04	0.14	0.23
Net Cash (Debt)	4.02	4.02	10.14	11.83	10.83	19.01
Net Cash Growth	-9.47%	-60.32%	-14.25%	9.25%	-43.04%	232.64%
Net Cash Per Share	0.00	0.00	0.01	0.01	0.02	0.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Cash Flow	-4.96	-4.96	-15.64	-10.12	-8.15	-7.81
Capital Expenditures	-0.01	-0.01	-0.01	-0	-0.03	-0
Free Cash Flow	-4.97	-4.97	-15.65	-10.12	-8.18	-7.81
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Gross Margin	78.74%	78.74%	90.71%	97.91%	98.32%	96.31%
Operating Margin	-566.19%	-566.19%	-827.68%	-401.45%	-579.21%	-328.10%
Pretax Margin	-568.01%	-568.01%	-828.51%	-401.57%	-579.19%	-326.89%
Profit Margin	-568.01%	-568.01%	-828.51%	-401.57%	-579.19%	-326.89%
FCF Margin	-589.03%	-589.03%	-868.97%	-340.93%	-416.36%	-439.23%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 22, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
PS Ratio	9.93	5.41	6.04	25.82	20.10	28.21